Document is current
Any future updates will be listed below
-
Authors
Monroig-Rivera, Carlos https://orcid.org/0000-0002-5147-2716
Thornberg, David https://orcid.org/0000-0002-6876-0458
Sucato, Daniel https://orcid.org/0000-0003-3352-5551
Rathjen, Karl https://orcid.org/0000-0003-3747-7593
McIntosh, Amy L. https://orcid.org/0000-0002-3660-4901
Ramo, Brandon https://orcid.org/0000-0003-1445-230X
- License Information
-
More Information
Article History
Received: 16 January 2025
Accepted: 2 June 2025
First Online: 22 June 2025
Declarations
:
: Dr. Brandon Ramo, Dr. Carlos Monroig-Rivera, and Mr. David Thornberg have no relevant financial or non-financial interests to disclose. Dr. Daniel Sucato has no relevant financial or non-financial interests to disclose related to this work, however, he receives royalties from Globus Medical. Dr. Karl Rathjen has no relevant financial or non-financial interests to disclose related to this work, however, he holds stocks/stock options with Mati Therapeutics. Dr. Amy L. McIntosh has no relevant financial or non-financial interests to disclose related to this work, however, she is a part of the Pediatric Advisory Council for Globus/NuVasive and a consultant for Medtronic.
: IRB approval was received before the study began. Participants were prospectively enrolled. Informed consent was obtained prior to initiation. (IRB #062015–098).
